Eighth New Drug Seminar on L-Asparaginase and Daunorubicin: December 17, 1979 Bethesda, Maryland
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
U.S. Dep. of Health and Human Services
1981
|
| Schriftenreihe: | Cancer treatment reports / Supplement
65,4 |
| Schlagworte: | |
| Beschreibung: | 130 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007589386 | ||
| 003 | DE-604 | ||
| 005 | 20001031 | ||
| 007 | t | ||
| 008 | 930421s1981 d||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)8878539 | ||
| 035 | |a (DE-599)BVBBV007589386 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 | ||
| 050 | 0 | |a RC271.C5 | |
| 111 | 2 | |a New Drug Seminar on L-Asparaginase and Daunorubicin |n 8 |d 1979 |c Bethesda, Md. |j Verfasser |0 (DE-588)5302059-5 |4 aut | |
| 245 | 1 | 0 | |a Eighth New Drug Seminar on L-Asparaginase and Daunorubicin |b December 17, 1979 Bethesda, Maryland |c Division of Cancer Treatment, National Cancer Institute |
| 264 | 1 | |a Washington, DC |b U.S. Dep. of Health and Human Services |c 1981 | |
| 300 | |a 130 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer treatment reports / Supplement |v 65,4 | |
| 650 | 4 | |a Asparagin | |
| 650 | 4 | |a Asparaginase |v Congresses | |
| 650 | 4 | |a Asparaginase |x therapeutic use |v Congresses | |
| 650 | 4 | |a Cancer |x Chemotherapy |x Congresses | |
| 650 | 4 | |a Daunorubicin |v Congresses | |
| 650 | 4 | |a Daunorubicin |x therapeutic use |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Tumors |x Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 810 | 2 | |a Supplement |t Cancer treatment reports |v 65,4 |w (DE-604)BV000892924 |9 65,4 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004957882 | ||
Datensatz im Suchindex
| _version_ | 1804121899249172480 |
|---|---|
| any_adam_object | |
| author_corporate | New Drug Seminar on L-Asparaginase and Daunorubicin Bethesda, Md |
| author_corporate_role | aut |
| author_facet | New Drug Seminar on L-Asparaginase and Daunorubicin Bethesda, Md |
| author_sort | New Drug Seminar on L-Asparaginase and Daunorubicin Bethesda, Md |
| building | Verbundindex |
| bvnumber | BV007589386 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)8878539 (DE-599)BVBBV007589386 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01473nam a2200385 cb4500</leader><controlfield tag="001">BV007589386</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20001031 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1981 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)8878539</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007589386</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">New Drug Seminar on L-Asparaginase and Daunorubicin</subfield><subfield code="n">8</subfield><subfield code="d">1979</subfield><subfield code="c">Bethesda, Md.</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)5302059-5</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Eighth New Drug Seminar on L-Asparaginase and Daunorubicin</subfield><subfield code="b">December 17, 1979 Bethesda, Maryland</subfield><subfield code="c">Division of Cancer Treatment, National Cancer Institute</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">U.S. Dep. of Health and Human Services</subfield><subfield code="c">1981</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">130 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer treatment reports / Supplement</subfield><subfield code="v">65,4</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asparagin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asparaginase</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Asparaginase</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daunorubicin</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daunorubicin</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumors</subfield><subfield code="x">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Cancer treatment reports</subfield><subfield code="v">65,4</subfield><subfield code="w">(DE-604)BV000892924</subfield><subfield code="9">65,4</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004957882</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV007589386 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:05:18Z |
| institution | BVB |
| institution_GND | (DE-588)5302059-5 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004957882 |
| oclc_num | 8878539 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | 130 S. graph. Darst. |
| publishDate | 1981 |
| publishDateSearch | 1981 |
| publishDateSort | 1981 |
| publisher | U.S. Dep. of Health and Human Services |
| record_format | marc |
| series2 | Cancer treatment reports / Supplement |
| spelling | New Drug Seminar on L-Asparaginase and Daunorubicin 8 1979 Bethesda, Md. Verfasser (DE-588)5302059-5 aut Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland Division of Cancer Treatment, National Cancer Institute Washington, DC U.S. Dep. of Health and Human Services 1981 130 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer treatment reports / Supplement 65,4 Asparagin Asparaginase Congresses Asparaginase therapeutic use Congresses Cancer Chemotherapy Congresses Daunorubicin Congresses Daunorubicin therapeutic use Congresses Neoplasms drug therapy Congresses Tumors Congresses (DE-588)1071861417 Konferenzschrift gnd-content Supplement Cancer treatment reports 65,4 (DE-604)BV000892924 65,4 |
| spellingShingle | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland Asparagin Asparaginase Congresses Asparaginase therapeutic use Congresses Cancer Chemotherapy Congresses Daunorubicin Congresses Daunorubicin therapeutic use Congresses Neoplasms drug therapy Congresses Tumors Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland |
| title_auth | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland |
| title_exact_search | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland |
| title_full | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland Division of Cancer Treatment, National Cancer Institute |
| title_fullStr | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland Division of Cancer Treatment, National Cancer Institute |
| title_full_unstemmed | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin December 17, 1979 Bethesda, Maryland Division of Cancer Treatment, National Cancer Institute |
| title_short | Eighth New Drug Seminar on L-Asparaginase and Daunorubicin |
| title_sort | eighth new drug seminar on l asparaginase and daunorubicin december 17 1979 bethesda maryland |
| title_sub | December 17, 1979 Bethesda, Maryland |
| topic | Asparagin Asparaginase Congresses Asparaginase therapeutic use Congresses Cancer Chemotherapy Congresses Daunorubicin Congresses Daunorubicin therapeutic use Congresses Neoplasms drug therapy Congresses Tumors Congresses |
| topic_facet | Asparagin Asparaginase Congresses Asparaginase therapeutic use Congresses Cancer Chemotherapy Congresses Daunorubicin Congresses Daunorubicin therapeutic use Congresses Neoplasms drug therapy Congresses Tumors Congresses Konferenzschrift |
| volume_link | (DE-604)BV000892924 |
| work_keys_str_mv | AT newdrugseminaronlasparaginaseanddaunorubicinbethesdamd eighthnewdrugseminaronlasparaginaseanddaunorubicindecember171979bethesdamaryland |